检索结果 - Patrik Olekšák
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
-
5
-
6
Frentizole derivatives with mTOR inhibiting and senomorphic properties 由 Žofia Chrienová, David Rysanek, Josef Novák, Pavla Vašicová, Patrik Olekšák, Rudolf Andrýs, Adam Skarka, J. Dumanović, Zoran Milovanović, Vesna Jaćević, Markéta Chvojková, Kristína Holubová, Karel Valeš, Veronika Skoupilova, Marián Valko, Klaudia Jomová, Suliman Yousef Alomar, Fernanda D. Botelho, Tanos C. C. França, Kamil Kuča, Zdeněk Hodný, Eugenie Nepovimová
出版 2023Artigo -
7
Erratum to “Frentizole derivatives with mTOR inhibiting and senomorphic properties” [Biomed. Pharmacother. 167 (2023) 115600] 由 Žofia Chrienová, David Rysanek, Josef Novák, Pavla Vašicová, Patrik Olekšák, Rudolf Andrýs, Adam Skarka, J. Dumanović, Zoran Milovanović, Vesna Jaćević, Markéta Chvojková, Kristína Holubová, Karel Valeš, Veronika Skoupilova, Marián Valko, Klaudia Jomová, Suliman Yousef Alomar, Fernanda D. Botelho, Tanos C. C. França, Kamil Kuča, Zdeněk Hodný, Eugenie Nepovimová
出版 2025Errata/Corrigenda
相关主题
Biology
Medicine
Pharmacology
Genetics
Apoptosis
Biochemistry
Chemistry
Ecology
Internal medicine
PI3K/AKT/mTOR pathway
2019-20 coronavirus outbreak
Acute toxicity
Anesthesia
Antibacterial activity
Antibacterial peptide
Antibiotics
Antimicrobial
Antimicrobial peptides
Bacteria
Biotechnology
Business
CRISPR
Computer science
Coronavirus disease 2019 (COVID-19)
Data science
Disease
Drug
Drug development
Drug discovery
Drug repositioning